BioConsortia secures $15 million in latest funding round

DAVIS, Calif.–(BUSINESS WIRE)–BioConsortia secures $15 million funding for broadened field trials, expansion of Davis, CA lab, gene-editing and Nitrogen fixing microbial products.
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks